No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
VTRS240621P15000
- 2.20
- 0.000.00%
15min DelayClose Feb 21 11:05 ET
0.00High0.00Low
0.00Open2.20Pre Close0 Volume0 Open Interest15.00Strike Price0.00Turnover0.00%IV22.72%PremiumJun 21, 2024Expiry Date4.57Intrinsic Value100Multiplier-4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma4.74Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Express News | Viatris Statement Regarding European Commission’s Approval for Proposed Divestiture of Its Over-the-Counter Business to Cooper Consumer Health
EU: Meeting Conditions Would Address Competition Concerns of Merger
EU: Meeting Conditions Would Address Competition Concerns of Merger
Express News | EU Approval Conditional on Cooper Selling Rights and Interests in Infant Laxative Medicine and Earwax Removal Product
Express News | Cooper Consumer Health Gains EU Antitrust Approval to Buy Viatris' European Over-the-Counter Drug Business
Viatris Named to TIME's World's Most Sustainable Companies 2024 List
Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to the inaugural edition of TIME's World's Most...
Goldman's Top 50 High Sharpe Ratio Stocks
Goldman Sachs analysts rebalanced their “high Sharpe Ratio” basket, which identifies 50 S&P 500 (SP500) stocks with the highest prospective risk-adjusted returns compared to their sector peers.